MC
ABBV icon

Miles Capital’s AbbVie ABBV Stock Holding History

Miles Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11,431
Closed -$921K – 181
2019
Q1 		$921K Buy
11,431
+482
+4% +$39.4K 0.8% 33
2018
Q4 		$1.01M Sell
10,949
-62
-0.6% -$5.45K 1% 20
2018
Q3 		$1.04M Sell
11,011
-2,229
-17% -$211K 0.84% 29
2018
Q2 		$1.23M Sell
13,240
-222
-2% -$21.7K 0.76% 22
2018
Q1 		$1.27M Sell
13,462
-3,072
-19% -$337K 0.7% 25
2017
Q4 		$1.6M Sell
16,534
-15
-0.1% -$1.41K 0.93% 13
2017
Q3 		$1.47M Sell
16,549
-1,010
-6% -$76.9K 0.83% 13
2017
Q2 		$1.27M Sell
17,559
-125
-0.7% -$8.4K 0.68% 24
2017
Q1 		$1.15M Sell
17,684
-1,448
-8% -$91K 0.64% 32
2016
Q4 		$1.2M Buy
19,132
+1,082
+6% +$66K 0.73% 28
2016
Q3 		$1.14M Buy
18,050
+2,318
+15% +$150K 0.77% 28
2016
Q2 		$974K Buy
15,732
+4,567
+41% +$278K 0.66% 28
2016
Q1 		$638K Sell
11,165
-3
-0% -$167 0.43% 52
2015
Q4 		$662K Buy
11,168
+4
+0% +$230 0.45% 57
2015
Q3 		$607K Sell
11,164
-726
-6% -$47.3K 0.44% 61
2015
Q2 		$799K Sell
11,890
-55
-0.5% -$3.59K 0.52% 45
2015
Q1 		$699K Buy
+11,945
New +$722K 0.42% 58
2013
Q3 		– Sell
-7,297
Closed -$302K – 117
2013
Q2 		$302K Buy
+7,297
New +$319K 0.14% 110

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Miles Capital's ABBV Position: Q2 2019 in Review

Miles Capital sold out of AbbVie (ABBV) in Q2 2019, closing a stake of 11,431 shares — an estimated $921K sold.

Miles Capital first reported a position in ABBV in Q2 2013 and held it in 18 quarters. The position peaked at $1.6M in Q4 2017. 2,020 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

  • Miles Capital reported no remaining AbbVie position as of Q2 2019 after selling out during the quarter.
  • Miles Capital sold 11,431 AbbVie shares in Q2 2019, an estimated $921K.
  • Miles Capital first reported a position in AbbVie in Q2 2013 and held it in 18 quarters.
  • Miles Capital's AbbVie position peaked at $1.6M in Q4 2017.
  • 2,020 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Miles Capital's 13F filing for Q2 2019, filed 13 Aug 2019.